CONTENTS:
- Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S. Curran L., Manuel J., art. 104342.
- Health warning labels on cannabis products. What is the best design? Gantiva C., Illidge-Cortes J., Gonzalez-Millares D., Maldonado-Hoyos V., Valencia L., art. 104355.
- High levels of all-cause mortality among people who inject drugs from 2018 to 2022. Roussos S., Angelopoulos T., Cholongitas E., Savvanis S., Papadopoulos N., Kapatais A., et al., art. 104356.
- Drug use and the constitution of homo politicus in Swedish politics 1966-1979. Roumeliotis F., art. 104357.
- Responding to 'wicked problems': policy and governance on drug-related deaths in English and Welsh prisons, 2015-2021. Duke K., MacGregor S., art. 104358.
- Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence. Lancaster K., Gendera S., Treloar C., Rhodes T., Shahbazi J., Byrne M., et al., art. 104359.
- Effects of strength of relationship ties in recovery homes: A conundrum. Jason L.A., Light J.M., Bobak T., Bell J., art. 104360.
- Tobacco research and public health messaging needs to be realigned to support more effective FDA rulemaking - A commentary on Shadel, et al., "Doing more with less: A proposal to advance cigarette packaging labeling in the United States". Lindblom E.N., art. 104361.
- An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada. Richardson L., Geddes C., Palis H., Buxton J., Slaunwhite A., art. 104362.
- Individual differences in legal and illicit cannabis purchasing behaviour in British Columbia, Canada: Findings from a 2021 cross-sectional survey. Maillet M.A., art. 104363.
- Longitudinal patterns of use of stimulants and opioids in the AIDS linked to the IntraVenous experience cohort, 2005-2019. Rudolph J.E., Cepeda J.A., Astemborski J., Kirk G.D., Mehta S.H., German D., et al., art. 104364.
- In pursuit of safer supply: An emerging evidence base for medical and nonmedical models. Nielsen S., Stowe M.J., Ritter A., art. 104365.
- Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California. Wenger L.D., Morris T., Knight K.R., Megerian C.E., Davidson P.J., Suen L.W., et al., art. 104366.
- Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK. Poulter H.L., Moore H.J., Ahmed D., Riley F., Walker T., Harris M., art. 104367.
- The Coloniality of drug prohibition. Dertadian G.C., art. 104368.
- Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia. Ahmad A., Bromberg D.J., Shrestha R., Salleh N.A.M., Bazazi A.R., Kamarulzaman A., et al., art. 104369.
- Public support for reinvesting resources from enforcing drug possession to health-promoting alternatives: A nationally representative poll of adults in the United States. Tomko C., Rouhani S., LaSalle L., Sherman S.G., art. 104370.
- Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States. Schneider K.E., Martin E.M., Allen S.T., Morris M., Haney K., Saloner B., et al., art. 104371.
- The association between excise taxes and smoking and vaping transitions - Findings from the 2016-2020 ITC United States surveys. He Y., Fong G.T., Cummings K.M., Hyland A., Shang C., art. 104372.
- Punitive legal responses to prenatal drug use in the United States: A survey of state policies and systematic review of their public health impacts. Bruzelius E., Underhill K., Askari M.S., Kajeepeta S., Bates L., Prins S.J., et al., art. 104380.
- Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis. Roy P.J., Suda K., Luo J., Lee M., Anderton J., Olejniczak D., et al., art. 104381.
- Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention. Acheson L.S., Clay S., McKetin R., Lintzeris N., Dunlop A., Brett J., et al., art. 104383.
- Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit. Walker S.J., Shrestha L.B., Lloyd A.R., Dawson O., Sheehan Y., Sheehan J., et al., art. 104386.